Stocks · Health care · Pharmaceutical Preparations

Aldeyra Therapeutics, Inc.

ALDX Clue Score54

United States Fiscal year ends December CIK 0001341235

Add to watchlist

By person

5 insiders · 3 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Todd C Brady

President and CEO

$418.45K (1)

—

+$418.45K

1,721,298

2.85%

$2.88M

+17.0%

Richard Douglas

Director

$98.00K (1)

—

+$98.00K

195,000

0.3232%

$326.39K

+56.0%

Michael Alfieri

Principal Financial Officer

$7.10K (1)

—

+$7.10K

7,500

0.0124%

$12.55K

—

Perceptive Advisors LLC entity

10% owner

—

5,875,851

9.74%

$9.83M

−36.7%

Stephen Machatha

Chief Development Officer

—

221,799

0.3677%

$371.25K

−9.1%

Aldeyra Therapeutics, Inc.

What the insiders did Net buying

By person